- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Idiopathic inflammatory myopathies.
Displaying page 1 of 1.
EudraCT Number: 2021-005202-98 | Sponsor Protocol Number: 80202135IIM2001 | Start Date*: 2022-11-08 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Nipocalimab in Participants with Active Idiopathic Inflammatory Myo... | |||||||||||||
Medical condition: Active Idiopathic Inflammatory Myopathies (IIM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) HU (Trial now transitioned) CZ (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004766-26 | Sponsor Protocol Number: NL58747 | Start Date*: 2017-03-08 |
Sponsor Name:Academic Medical Center | ||
Full Title: Intravenous immunoglobulins as early treatment in newly diagnosed idiopathic inflammatory myopathies (IMMEDIATE): a pilot study. | ||
Medical condition: idiopathic inflammatory myopathies | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000391-15 | Sponsor Protocol Number: AIFA-2016-02364869 | Start Date*: 2018-06-05 | |||||||||||||||||||||
Sponsor Name:Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia | |||||||||||||||||||||||
Full Title: Multicentric, open-label, prospective study of subcutaneous tocilizumab in adult patients with refractory myositis | |||||||||||||||||||||||
Medical condition: Myositis (dermatomyositis [DM] or polymyositis [PM]) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001710-37 | Sponsor Protocol Number: NL73727 | Start Date*: 2021-05-26 |
Sponsor Name:Academisch Medisch Centrum | ||
Full Title: Intravenous immunoglobulin and prednisone vs. prednisone in newly diagnosed myositis: a double blind randomized clinical trial. | ||
Medical condition: idiopathic inflammatory myopathies | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003171-35 | Sponsor Protocol Number: IgPro20_3007 | Start Date*: 2019-09-24 | |||||||||||
Sponsor Name:CSL Behring LLC | |||||||||||||
Full Title: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra®) in Adults with Dermatomyositis (DM) | |||||||||||||
Medical condition: Dermatomyositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) DE (Trial now transitioned) BE (Trial now transitioned) IT (Trial now transitioned) HU (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
